Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China.

Vaccine - 3 Mar 2011

Liu Xinyu, Yu Yongxin, Li Maoguang, Liang Guodong, Wang Huanyu, Jia Lili, Dong Guanmu

Abstract excerpt

Prior to 1976 only Japanese encephalitis virus (JEV) genotype III could be detected in China. Recently, numerous genotype I JEV strains have been isolated from JE patients, mosquitoes and pigs while genotype III strains remain present. Two kinds of JEV vaccines are currently used in China for the prevention disease: the JE live attenuated vaccine (LAV) SA14-14-2 virus and the inactivated P3 strain (IPV) vaccine....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to China

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Culicidae

Share to Encephalitis, Japanese

Share to Encephalitis Virus, Japanese

Share to Neutralization Tests

Share to Vaccines, Attenuated

Source

Identifiers

PMID: 21237278
DOI: 10.1016/j.vaccine.2010.12.108

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China.PMID 21237278Read ↗

Study on the Protective Efficacy of the Japanese Encephalitis Live Attenuated Vaccine SA14-14-2 Against Newly Isolated Genotype I Japanese Encephalitis Viruses.Semantic proximity Read ↗

Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities.Semantic proximity Read ↗

Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.Semantic proximity Read ↗

Japanese encephalitis and Japanese encephalitis virus in mainland China.Semantic proximity Read ↗

Comparison of Neutralizing Antibody Titers against Japanese Encephalitis Virus Genotype V Strain with Those against Genotype I and III Strains in the Sera of Japanese Encephalitis Patients in Japan in 2016.Semantic proximity Read ↗

Partial cross-protection between Japanese encephalitis virus genotype I and III in miceSemantic proximity Read ↗

[Progress in the research of phenotype and genotype of Japanese encephalitis virus in China].Semantic proximity Read ↗

Shift in dominant genotypes of Japanese encephalitis virus and its impact on current vaccination strategiesSemantic proximity Read ↗

Comparison of the live-attenuated Japanese encephalitis vaccine SA14 -14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivoSemantic proximity Read ↗

Biological and genetic properties of SA14-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humansSemantic proximity Read ↗

Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.Semantic proximity Read ↗

Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.